CeriBell (NASDAQ:CBLL) Hits New 1-Year High – What’s Next?

Posted by Francis Steltz on Oct 23rd, 2026

CeriBell, Inc. (NASDAQ:CBLL – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $28.11 and last traded at $27.66, with a volume of 58,393 shares changing hands. The stock had previously closed at $27.68.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CBLL shares. BTIG Research restated a “buy” rating and issued a $30.00 price target on shares of CeriBell in a report on Friday, September 11th. Barclays upgraded CeriBell to a “neutral” rating in a report on Tuesday, August 18th. TD Cowen lifted their target price on CeriBell from $29.00 to $33.00 and gave the company a “buy” rating in a research report on Friday, October 2nd. Weiss Ratings upgraded CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 16th. Finally, Canaccord Genuity Group upped their price target on CeriBell from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, CeriBell presently has an average rating of “Moderate Buy” and a consensus price target of $27.00.

Read Our Latest Report on CeriBell

CeriBell Stock Up 1.0%

The firm has a market cap of $1.05 billion, a P/E ratio of -15.57 and a beta of 0.94. The company has a quick ratio of 8.79, a current ratio of 9.18 and a debt-to-equity ratio of 0.16. The firm has a fifty day moving average of $24.58 and a 200-day moving average of $20.93.

CeriBell (NASDAQ:CBLL – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The company had revenue of $28.10 million during the quarter, compared to the consensus estimate of $27.28 million. CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. On average, equities research analysts anticipate that CeriBell, Inc. will post -1.96 earnings per share for the current year.

Insider Buying and Selling

In other news, CRO Joseph Manni sold 1,361 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $24.02, for a total value of $32,691.22. Following the completion of the sale, the executive owned 55,956 shares of the company’s stock, valued at approximately $1,344,063.12. This represents a 2.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Xingjuan Chao sold 20,846 shares of the firm’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $25.03, for a total transaction of $521,775.38. Following the completion of the transaction, the chief executive officer directly owned 746,345 shares of the company’s stock, valued at $18,681,015.35. This represents a 2.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 174,905 shares of company stock worth $4,312,995 in the last quarter. 17.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Sei Investments Co. increased its stake in shares of CeriBell by 2.3% during the 1st quarter. Sei Investments Co. now owns 50,360 shares of the company’s stock worth $923,000 after purchasing an additional 1,125 shares during the last quarter. Strs Ohio bought a new stake in shares of CeriBell in the 1st quarter valued at about $27,000. Caitong International Asset Management Co. Ltd lifted its stake in CeriBell by 8,735.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,739 shares of the company’s stock valued at $60,000 after purchasing an additional 2,708 shares during the last quarter. Legal & General Group Plc acquired a new stake in CeriBell in the 2nd quarter valued at about $53,000. Finally, State of Wyoming bought a new position in CeriBell during the first quarter worth about $62,000.

About CeriBell

(Get Free Report)

CeriBell, Inc is a medical technology company that develops artificial intelligence-enabled neurological diagnostic products. Its technology is designed to help healthcare professionals rapidly identify and monitor seizures, including nonconvulsive seizures that may be difficult to recognize through a standard clinical examination.

The company’s primary product is the Ceribell Rapid Response EEG system, a portable electroencephalography platform that combines a wireless EEG recorder, a simplified disposable headband, and software-based analysis tools.